Testing effectiveness (Phase 2)Active Not RecruitingNCT07220577
What this trial is testing
Phase 2a Study to Assess the Efficacy,Safety and Tolerability of GIA632 in Adult Participants With Moderate to Severe Atopic Dermatitis
Who this might be right for
Atopic Dermatitis
Novartis Pharmaceuticals 34